Proposal for standardization of 2019-nCoV nucleic acid detection in clinical laboratories
10.3760/cma.j.issn.1009-9158.2020.03.002
- VernacularTitle:新型冠状病毒核酸检测临床实验室操作规范的建议
- Author:
Yongqing TONG
1
;
Ming WANG
;
Wanzhou XU
;
Bin QIAO
;
Hongyun ZHENG
;
Siqing MEI
;
Xiaoyun HE
;
Ping'an ZHANG
;
Yan LI
Author Information
1. 武汉大学人民医院检验医学中心，武汉 430060
- From:
Chinese Journal of Laboratory Medicine
2020;43(3):209-212
- CountryChina
- Language:Chinese
-
Abstract:
In December, the outbreak of a novel coronavirus (2019-nCoV) in Wuhan, China, has attracted extensive global attention. On January 20, 2020, the Chinese health authorities upgraded the coronavirus to a Class B infectious disease in the Law of the People′s Republic of China on the Prevention and Treatment of Infectious Diseases, and considered it as Class A infectious diseases in disease control and prevention. On January 18, 2020, the 2019-nCoV nucleic acid detection test was listed as the diagnostic criteria in the "guidelines for diagnosis and treatment of pneumonia due to 2019-nCoV (Trial Version 2)" . Therefore, standardizing the operation process of the 2019-nCoV nucleic acid detection in clinical laboratories has become a top priority. It is of paramount importance to establish standard protocols for detection of the 2019-nCoV nucleic acids in clinical laboratories to improve the reliability of the results and ensure the biosafety of laboratory personnel.
